GLP-1RA Effects on Lean Mass and Bone Health in Midlife Women
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age35-60
SponsorUniversity of Kansas Medical Center
About this trial
This study is designed with the interest to learn on the effects of estrogen levels and how it affects body compositions and muscle function in midlife women who are taking a GLP-1RA for weight loss.
Eligibility criteria
Qualifiers
Females
Age 35-60 year
BMI≥30 or BMI≥27 and at least one cardiometabolic risk factor (dyslipidemia, hypertension, obstructive sleep apnea, metabolic syndrome, fatty liver, PCOS)
Newly prescribed a GLP-1RA medication
Disqualifiers
Pregnant women
Under age 35 or over age 60
Born male
Cannot consent for themselves
Trial design
Treatments tested in this trial
- Not listed
Trial groups
50 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov